Tag: vaccine adjuvants market forecast

Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Are The Market Size Estimates For The Vaccine Adjuvants Market?

Strong growth in recent years has been demonstrated by the vaccine adjuvants market. The market size, which was $1.89 billion in 2024, is projected to increase to $2.01 billion in 2025 with a compound annual growth rate (CAGR) of 6.6%. The notable growth experienced during the historic period can be credited to factors such as the growth in vaccine development, the spread of infectious diseases, government-backed initiatives and immunization programs, investment in research and development, and the globalization of vaccine distribution.

In the upcoming years, the vaccine adjuvants market is projected to experience robust growth. It is forecasted to reach $2.83 billion in 2029, growing at a compound annual growth rate (CAGR) of 8.9%. This growth during the forecast period can be ascribed to preparedness for pandemics, the broadening vaccine portfolio, global vaccination targets, collaborations and partnerships, as well as focus on therapeutic vaccines. Noteworthy trends during the forecast period will be improvements in adjuvant technologies, emphasis on boosting immunogenicity, combined adjuvants for augmented effectiveness, a need for safer and well-tolerated adjuvants, plus personalized vaccines and adjuvants.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10121&type=smp

What Market Forces Are Contributing To The Growth Of The Vaccine Adjuvants Market?

The escalating incidence of infectious diseases is poised to fuel the expansion of the vaccine adjuvants market in the future. These infectious diseases include ailments caused by viruses, bacteria, fungi, or parasites. Vaccines provide a remedy for these infectious diseases, which include hepatitis B (HBV), hepatitis C (HCV), HIV, malaria, syphilis, and brucellosis. For example, the World Health Organization (WHO) report in 2022 indicates that approximately 10.6 million individuals around the world contracted tuberculosis in 2021. Out of those infected, 1.6 million succumbed to the disease, and 1.5 million additional individuals were diagnosed with HIV. Additionally, 650,000 people perished due to HIV during the same year. Consequently, the increasing instances of infectious diseases will stimulate the growth of the vaccine adjuvants market.

How Is The Vaccine Adjuvants Market Categorized Across Applications And Types?

The vaccine adjuvants market covered in this report is segmented –

1) By Product Type: Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, Other Product Types

2) By Route of Application: Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants

3) By Route of Administration: Oral, Intramuscular, Intranasal, Subcutaneous, Intradermal

4) By Disease: Cancer, Infectious Diseases, Other Diseases

Subsegments:

1) By Adjuvant Emulsions: Oil-In-Water Emulsions, Water-In-Oil Emulsions

2) By Pathogen Components: Bacterial Components, Viral Components

3) By Particulate Adjuvants: Liposomes, Nanoparticles, Microparticles

4) By Combination Adjuvants: Mixed Emulsions, Multiple Component Systems

5) By Other Product Types: Synthetic Adjuvants, Natural Adjuvants

How Are Market Trends Influencing Competition In The Vaccine Adjuvants Market?

In the vaccine adjuvants market, one prevailing trend is the emergence of product innovations. Companies in this sector are prioritizing inventive solutions to bolster their market standing. An apt illustration of this is Evonik Industries’ move in December 2022. The Germany-based chemical manufacturing firm launched PhytoSquene, a plant-based squalene sourced from amaranth oil, presenting an eco-friendly substitute for the conventional shark-derived squalene. This innovation is intended for use in vaccine adjuvants and other pharmaceutical applications, aiming to enhance vaccine effectiveness by amplifying immune responses. This progressive step with PhytoSquene underlines the increasingly important role of sustainability in the pharmaceutical industry.

Who Are The Most Influential Companies In The Vaccine Adjuvants Market?

Major companies operating in the vaccine adjuvants market include GlaxoSmithKline Plc., Novavax Inc., SPI Pharma Inc., Agenus Inc., CSL Limited, InvivoGen Limited., Brenntag Biosector A/S, Adjuvatis, Merck KGaA, Croda International Plc, Seppic Inc, OZ Biosciences, Avanti Polar Lipids Inc, Astellas Pharma Inc, Virometix AG, MPV Technologies Limited, Adjuvance Technologies Inc., Novartis AG, Vaxine Pty Ltd, SBI Biotech Co. Ltd., Statens Serum Institute, GSK Vaccines, VaxLiant LLC, VaxForm LLC, Serum Institute of India, Dynavax Technologies Corporation, Vaxcyte Inc., VBI Vaccines Inc., Medicago Inc., Aphios Corporation

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/vaccine-adjuvants-global-market-report

Which Region Holds The Greatest Opportunity For Vaccine Adjuvants Market Expansion?

North America was the largest region in the vaccine adjuvants market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global vaccine adjuvants market report during the forecast period. The regions covered in the vaccine adjuvants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=10121&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Forecasted Growth Rate and Market Size of the Vaccine Adjuvants Market?

The vaccine adjuvants industry has seen dynamic growth in the past years. The market is expected to rise from $1.89 billion in 2024 to $2.01 billion in 2025, with an annual compound growth rate (CAGR) of 6.6%. This notable growth during the previous period is largely due to the rise in vaccine development, the prevalence of infectious diseases, the initiation of government programs for immunization, investments in research and development, and the globalization of vaccine distribution.

The market size of vaccine adjuvants is projected to experience robust growth in the upcoming years, escalating to $2.83 billion by 2029 with a compound annual growth rate (CAGR) of 8.9%. Factors contributing to this growth in the prediction period include readiness for pandemics, an increasing vaccine portfolio, international immunization objectives, collaborations, and strategic partnerships, and an emphasis on therapeutic vaccines. Trends expected during this prediction period are developments in adjuvant technologies, increased focus on improving immunogenicity, the use of combined adjuvants for heightened effectiveness, the need for safer and better-tolerated adjuvants, and the emergence of personalized vaccines and adjuvants.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10121&type=smp

Which Factor Is Shaping The Future Of The Vaccine Adjuvants Market?

The escalating frequency of infectious diseases has the potential to boost the growth of the vaccine adjuvants market in the future. These diseases, induced by viruses, bacteria, fungi, or parasites, are treated with immunizations for conditions like hepatitis B (HBV), hepatitis C (HCV), HIV, malaria, syphilis, and brucellosis. To illustrate, the 2022 report from the World Health Organization (WHO) revealed that there were around 10.6 million global tuberculosis cases in 2021, resulting in 1.6 million deaths. Moreover, in the same year, 1.5 million people contracted HIV, and 650,000 people succumbed to the disease. Therefore, the increasing occurrence of infectious diseases will enhance the growth of the vaccine adjuvants market.

The vaccine adjuvants market covered in this report is segmented –

1) By Product Type: Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, Other Product Types

2) By Route of Application: Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants

3) By Route of Administration: Oral, Intramuscular, Intranasal, Subcutaneous, Intradermal

4) By Disease: Cancer, Infectious Diseases, Other Diseases

Subsegments:

1) By Adjuvant Emulsions: Oil-In-Water Emulsions, Water-In-Oil Emulsions

2) By Pathogen Components: Bacterial Components, Viral Components

3) By Particulate Adjuvants: Liposomes, Nanoparticles, Microparticles

4) By Combination Adjuvants: Mixed Emulsions, Multiple Component Systems

5) By Other Product Types: Synthetic Adjuvants, Natural Adjuvants

Which Emerging Trends And Strategic Shifts Are Shaping The Vaccine Adjuvants Market?

One of the main trends seen in the vaccine adjuvants market revolves around product innovation. Players in this market are strategically adopting innovative solutions to solidify their standing. Evonik Industries, a Germany-based company specializing in chemical manufacturing, for instance, rolled out PhytoSquene in December 2022. This plant-based product derived from amaranth oil is a sustainable substitute for the conventional shark-derived squalene, and is primed for usage in vaccine adjuvants as well as other pharmaceutical applications in order to augment vaccine effectiveness by catalyzing immune responses. This move underscores the growing focus on sustainability within the pharmaceutical industry.

Which Companies Hold The Largest Market Share In The Vaccine Adjuvants Sector?

Major companies operating in the vaccine adjuvants market include GlaxoSmithKline Plc., Novavax Inc., SPI Pharma Inc., Agenus Inc., CSL Limited, InvivoGen Limited., Brenntag Biosector A/S, Adjuvatis, Merck KGaA, Croda International Plc, Seppic Inc, OZ Biosciences, Avanti Polar Lipids Inc, Astellas Pharma Inc, Virometix AG, MPV Technologies Limited, Adjuvance Technologies Inc., Novartis AG, Vaxine Pty Ltd, SBI Biotech Co. Ltd., Statens Serum Institute, GSK Vaccines, VaxLiant LLC, VaxForm LLC, Serum Institute of India, Dynavax Technologies Corporation, Vaxcyte Inc., VBI Vaccines Inc., Medicago Inc., Aphios Corporation

https://www.thebusinessresearchcompany.com/report/vaccine-adjuvants-global-market-report

How Does Regional Performance Compare Across The Vaccine Adjuvants Industry?

North America was the largest region in the vaccine adjuvants market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global vaccine adjuvants market report during the forecast period. The regions covered in the vaccine adjuvants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10121&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Current and Projected Market Size of the Vaccine Adjuvants Industry?

There has been substantial growth in the vaccine adjuvants market size in the past few years. The market, which is anticipated to increase from $1.89 billion in 2024 to $2.01 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.6%. Factors such as enhanced vaccine development, rise in infectious diseases, government-driven initiatives and immunization programs, investments in research and development, and the global spread of vaccine distribution have largely contributed to this historical growth.

The market size for vaccine adjuvants is projected to experience significant growth in the upcoming years, increasing to $2.83 billion by 2029 with a compound annual growth rate (CAGR) of 8.9%. This predicted growth during the forecast period is due to factors such as preparedness for pandemics, an increasing range of vaccines, worldwide immunization objectives, partnerships and collaborations, and a focus on therapeutic vaccines. Key trends for the forecast period comprise advancements in adjuvant technologies, efforts to improve immunogenicity, the use of combination adjuvants for greater efficacy, demand for safer and more tolerated adjuvants, and personalized vaccines and adjuvants.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10121&type=smp

#Which Factors Are Currently Driving The Growth Of The Vaccine Adjuvants Market?

The growth of the vaccine adjuvants market is anticipated to be driven by the increasing occurrence of infectious diseases. These infectious diseases, caused by viruses, bacteria, fungi, or parasites, include conditions like hepatitis B (HBV), hepatitis C (HCV), HIV, malaria, syphilis, and brucellosis, which are treated using vaccines. The 2022 report from the World Health Organization (WHO) highlighted that an estimated 10.6 million people worldwide were affected by tuberculosis in 2021, with 1.6 million deaths, and another 1.5 million contracting HIV in the same year, leading to 650,000 fatalities. As such, the escalating rates of infectious diseases are expected to boost the vaccine adjuvants market.

How Is The Global Vaccine Adjuvants Market Structured In Terms Of Segments?

The vaccine adjuvants market covered in this report is segmented –

1) By Product Type: Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, Other Product Types

2) By Route of Application: Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants

3) By Route of Administration: Oral, Intramuscular, Intranasal, Subcutaneous, Intradermal

4) By Disease: Cancer, Infectious Diseases, Other Diseases

Subsegments:

1) By Adjuvant Emulsions: Oil-In-Water Emulsions, Water-In-Oil Emulsions

2) By Pathogen Components: Bacterial Components, Viral Components

3) By Particulate Adjuvants: Liposomes, Nanoparticles, Microparticles

4) By Combination Adjuvants: Mixed Emulsions, Multiple Component Systems

5) By Other Product Types: Synthetic Adjuvants, Natural Adjuvants

What Trends Are Currently Influencing Growth In The Vaccine Adjuvants Market?

Product innovation is an emerging trend that is becoming prominent in the travel vaccine market. In order to maintain their market stance, leading companies involved in the travel vaccine market are creating novel vaccines. For instance, Takeda Pharmaceutical Company Limited, a pharmaceutical firm based in Japan, received approval for QDENGA (Dengue Tetravalent Vaccine) (TAK-003) in August 2022. This approval was granted by the Indonesia National Agency for Drug and Food Control for the prevention of dengue disease caused by any serotype in individuals aged between six to 45. Independent of an individual’s previous exposure to the disease, QDENGA has proven to offer overall protection against dengue disease and hospitalization three years post-immunization.

Who Are The Main Participants Shaping The Vaccine Adjuvants Market Landscape?

Major companies operating in the vaccine adjuvants market include GlaxoSmithKline Plc., Novavax Inc., SPI Pharma Inc., Agenus Inc., CSL Limited, InvivoGen Limited., Brenntag Biosector A/S, Adjuvatis, Merck KGaA, Croda International Plc, Seppic Inc, OZ Biosciences, Avanti Polar Lipids Inc, Astellas Pharma Inc, Virometix AG, MPV Technologies Limited, Adjuvance Technologies Inc., Novartis AG, Vaxine Pty Ltd, SBI Biotech Co. Ltd., Statens Serum Institute, GSK Vaccines, VaxLiant LLC, VaxForm LLC, Serum Institute of India, Dynavax Technologies Corporation, Vaxcyte Inc., VBI Vaccines Inc., Medicago Inc., Aphios Corporation

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/vaccine-adjuvants-global-market-report

Which Region Currently Holds The Largest Share In The Vaccine Adjuvants Market?

North America was the largest region in the vaccine adjuvants market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global vaccine adjuvants market report during the forecast period. The regions covered in the vaccine adjuvants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10121&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Vaccine Adjuvants Market from 2024 to 2025?

There has been a robust growth in the vaccine adjuvants market in the recent years. The market, which valued at $1.89 billion in 2024, is expected to grow to $2.03 billion in 2025 with a compound annual growth rate (CAGR) of 7.6%. The surge in growth during the historic period is attributable to factors such as increased vaccine production, rise in pervasive diseases, government-backed initiatives and immunization programs, investment in research and development, and the international distribution of vaccines.

What Is the Projected Market Size of the Vaccine Adjuvants Market?

Expectations are high for robust expansion in the vaccine adjuvants market size in the upcoming years. It’s projected to climb to “$2.89 billion by 2029, with a compound annual growth rate (CAGR) of 9.2%. The anticipated growth during this forecasting phase is linked to readiness for pandemics, a broadening vaccine portfolio, worldwide immunization targets, combined efforts and alliances, and an emphasis on therapeutic vaccines. Key trends for the forecasting period include innovations in adjuvant technologies, a concentrated approach to boost immunogenicity, combination adjuvants for greater efficacy, the need for safer and better-tolerated adjuvants, and tailor-made vaccines and adjuvants.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10121&type=smp

Who are the Major Competitors in the Vaccine Adjuvants Market Outlook?

Major companies operating in the vaccine adjuvants market include GlaxoSmithKline Plc., Novavax Inc., SPI Pharma Inc., Agenus Inc., CSL Limited, InvivoGen Limited., Brenntag Biosector A/S, Adjuvatis, Merck KGaA, Croda International Plc, Seppic Inc, OZ Biosciences, Avanti Polar Lipids Inc, Astellas Pharma Inc, Virometix AG, MPV Technologies Limited, Adjuvance Technologies Inc., Novartis AG, Vaxine Pty Ltd, SBI Biotech Co. Ltd., Statens Serum Institute, GSK Vaccines, VaxLiant LLC, VaxForm LLC, Serum Institute of India, Dynavax Technologies Corporation, Vaxcyte Inc., VBI Vaccines Inc., Medicago Inc., Aphios Corporation

What Is Fueling Growth in the Vaccine Adjuvants Market?

The escalating occurrence of contagious illnesses is anticipated to spur the expansion of the vaccine adjuvants market. Contagious diseases encompass infections triggered by viruses, bacteria, fungi, or parasites. Vaccines are employed to counter these ailments such as hepatitis B (HBV), hepatitis C (HCV), HIV, malaria, syphilis, and brucellosis. For example, as per the 2022 data from the World Health Organization (WHO), an estimated 10.6 million individuals were infected with tuberculosis in 2021 worldwide, with 1.6 million fatalities and 1.5 million new cases of HIV infection in 2021 causing 650,000 deaths. Consequently, the increasing pervasiveness of infectious maladies will fuel the growth of the vaccine adjuvants market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10121&type=smp

Which Vaccine Adjuvants Market Segments Are Growing the Fastest?

The vaccine adjuvants market covered in this report is segmented –

1) By Product Type: Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, Other Product Types

2) By Route of Application: Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants

3) By Route of Administration: Oral, Intramuscular, Intranasal, Subcutaneous, Intradermal

4) By Disease: Cancer, Infectious Diseases, Other Diseases

Subsegments:

1) By Adjuvant Emulsions: Oil-In-Water Emulsions, Water-In-Oil Emulsions

2) By Pathogen Components: Bacterial Components, Viral Components

3) By Particulate Adjuvants: Liposomes, Nanoparticles, Microparticles

4) By Combination Adjuvants: Mixed Emulsions, Multiple Component Systems

5) By Other Product Types: Synthetic Adjuvants, Natural Adjuvants

Which Industry Trends Are Shaping the Future of the Vaccine Adjuvants Market?

Emerging trends in the vaccine adjuvants market are being dominated by product innovations. Businesses in this sector are leveraging novel solutions to solidify their market standing. An example of this occurred in December 2022, when Evonik Industries, a chemical manufacturing firm based in Germany, launched PhytoSquene, a plant-based squalene obtained from amaranth oil. This eco-friendly substitute to the conventional shark-derived squalene is crafted for utilization in vaccine adjuvants and several other pharmaceutical uses, boosting the effectiveness of vaccines by enhancing immune responses. The creation of PhytoSquene highlights the escalating focus on environmental sustainability within the pharmaceutical industry.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/vaccine-adjuvants-global-market-report

Which Countries Are Leading the Vaccine Adjuvants Market?

North America was the largest region in the vaccine adjuvants market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global vaccine adjuvants market report during the forecast period. The regions covered in the vaccine adjuvants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10121

This Report Delivers Insight On:

1. How big is the vaccine adjuvants market, and how is it changing globally?

2. Who are the major companies in the vaccine adjuvants market, and how are they performing?

3. What are the key opportunities and risks in the vaccine adjuvants market right now?

4. Which products or customer segments are growing the most in the vaccine adjuvants market?

5. What factors are helping or slowing down the growth of the vaccine adjuvants market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the vaccine adjuvants industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Is the Current and Projected Market Size of the Vaccine Adjuvants Market Through 2034?

The market for vaccine adjuvants has witnessed robust growth in the past few years. The estimated value is expected to increase from $1.89 billion in 2024 to $2.03 billion in 2025, with a compound annual growth rate (CAGR) of 7.6%. Factors contributing to this historic surge include heightened vaccine development, widespread infectious diseases, government-driven initiatives and immunization schemes, investment in research and development, and the global expansion of vaccine distribution.

The market size for vaccine adjuvants is projected to experience robust expansion in the coming years, reaching “$2.89 billion by 2029 with an impressive compound annual growth rate (CAGR) of 9.2%. This expected growth during the forecast period can be attributed to factors such as readiness for pandemics, broadened vaccine portfolios, global immunisation objectives, cooperative ventures and partnerships, and an emphasis on therapeutic vaccines. Trends to watch in this forecast period include improvement in adjuvant technologies, focus on enhancing immunogenicity, combined adjuvants for improved efficacy, the need for safer and better-tolerated adjuvants, and personalisation of vaccines and adjuvants.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10121&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Vaccine Adjuvants Market?

The growing incidence of infectious illnesses is predicted to boost the expansion of the vaccine adjuvants market. These infectious diseases are infections triggered by viruses, bacteria, fungi, or parasites, and vaccines are utilized to combat them, diseases like hepatitis B (HBV), hepatitis C (HCV), HIV, malaria, syphilis, and brucellosis included. For example, the 2022 World Health Organization (WHO) report shows that around 10.6 million people worldwide got infected with tuberculosis in 2021, 1.6 million of them eventually died while 1.5 million people contracted HIV in 2021, resulting in the death of 650,000 individuals. Consequently, the escalating incidence of infectious diseases will stimulate the growth of the vaccine adjuvants market.

Which Key Market Segments Comprise the Vaccine Adjuvants Market and Drive Its Revenue Growth?

The vaccine adjuvants market covered in this report is segmented –

1) By Product Type: Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, Other Product Types

2) By Route of Application: Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants

3) By Route of Administration: Oral, Intramuscular, Intranasal, Subcutaneous, Intradermal

4) By Disease: Cancer, Infectious Diseases, Other Diseases

Subsegments:

1) By Adjuvant Emulsions: Oil-In-Water Emulsions, Water-In-Oil Emulsions

2) By Pathogen Components: Bacterial Components, Viral Components

3) By Particulate Adjuvants: Liposomes, Nanoparticles, Microparticles

4) By Combination Adjuvants: Mixed Emulsions, Multiple Component Systems

5) By Other Product Types: Synthetic Adjuvants, Natural Adjuvants

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=10121&type=smp

Which Areas Are Leading Regions in the Vaccine Adjuvants Market Expansion Across the Globe?

North America was the largest region in the vaccine adjuvants market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global vaccine adjuvants market report during the forecast period. The regions covered in the vaccine adjuvants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Key Market Trends in theVaccine Adjuvants Market Over the Coming Years?

The emergence of novel product developments is a major trend gaining traction in the vaccine adjuvants market. Firms involved in the vaccine adjuvants market are concentrating on leveraging innovative solutions to fortify their stance within the market. For illustration, in December 2022, Evonik Industries, a chemical manufacturing corporation based in Germany, unveiled PhytoSquene, a plant-based squalene derived from amaranth oil. This eco-friendly substitute to traditional shark-derived squalene is developed for utilisation in vaccine adjuvants and additional pharmaceutical usages, enhancing vaccine potency by amplifying immune reactions. The creation of PhytoSquene highlights the increasing focus on sustainability within the pharmaceutical industry.

View the full report here:

https://www.thebusinessresearchcompany.com/report/vaccine-adjuvants-global-market-report

How Is the Vaccine Adjuvants Market Conceptually Defined?

Vaccine adjuvants are compounds or ingredients used in vaccines that enhance the body’s immunogenic response to antigens that lack immunostimulatory capabilities and help to create a stronger immune response.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10121

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Vaccine Adjuvants Market?

The growth of the vaccine adjuvants market is anticipated to be spurred on by the increasing incidence of infectious diseases. These diseases, caused by viruses, bacteria, fungi, or parasites, include hepatitis B (HBV), hepatitis C (HCV), HIV, malaria, syphilis, and brucellosis, and are treated using vaccines. For example, the World Health Organization’s 2022 report states that globally, in 2021, about 10.6 million people were infected with tuberculosis, 1.6 million of whom passed away. In addition, 1.5 million people contracted HIV, and 650,000 people succumbed to the condition. Consequently, the vaccine adjuvants market will be bolstered by the escalating prevalence of infectious diseases.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10121&type=smp

#What Growth Opportunities Will Drive the Vaccine Adjuvants Market’s CAGR Through 2034?

In the last few years, there has been considerable growth in the vaccine adjuvants market size. It is set to expand from $1.89 billion in 2024 to $2.03 billion in 2025, registering a compound annual growth rate (CAGR) of 7.6%. Factors contributing to this growth during the historic period include a surge in efforts towards vaccine development, the high frequency of infectious diseases, government-led initiatives and immunization programs, investment in research and development, and the global reach of vaccine distribution.

The market size for vaccine adjuvants is projected to witness robust expansion in the coming years. With a compound annual growth rate (CAGR) of 9.2%, it is predicted to reach “$2.89 billion by 2029. The anticipated surge in this period could be due to factors such as preparedness for pandemics, an expanding vaccine portfolio, worldwide immunization goals, collaborations and partnerships, and a focus on therapeutic vaccines. The period in question is also expected to see notable trends including technological advancements in adjuvants, emphasis on enhancing immunogenicity, combined adjuvants for improved efficacy, a call for safer and better tolerated adjuvants, and tailor-made vaccines and adjuvants.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10121

What Are the Key Market Innovations in theVaccine Adjuvants Market Over the Coming Years?

A prominent trend emerging in the vaccine adjuvants market is the advent of product innovations. Companies in this industry are turning towards inventive solutions to bolster their standing within the market. For instance, Evonik Industries, rooted in Germany and specializing in chemical manufacturing, launched PhytoSquene, a plant-based squalene extracted from amaranth oil, in December 2022. This eco-friendly alternative to conventional shark-derived squalene is intended for utilization in vaccine adjuvants and other medicinal applications, improving vaccine efficiency by enhancing immune responses. The unveiling of PhytoSquene underscores the increasing focus on sustainable practices within the pharmaceutical industry.

Who Are the Top Companies Driving Innovation and Growth in theVaccine Adjuvants Market?

Major companies operating in the vaccine adjuvants market include GlaxoSmithKline Plc., Novavax Inc., SPI Pharma Inc., Agenus Inc., CSL Limited, InvivoGen Limited., Brenntag Biosector A/S, Adjuvatis, Merck KGaA, Croda International Plc, Seppic Inc, OZ Biosciences, Avanti Polar Lipids Inc, Astellas Pharma Inc, Virometix AG, MPV Technologies Limited, Adjuvance Technologies Inc., Novartis AG, Vaxine Pty Ltd, SBI Biotech Co. Ltd., Statens Serum Institute, GSK Vaccines, VaxLiant LLC, VaxForm LLC, Serum Institute of India, Dynavax Technologies Corporation, Vaxcyte Inc., VBI Vaccines Inc., Medicago Inc., Aphios Corporation

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/vaccine-adjuvants-global-market-report

Which Key Market Segments Comprise the Vaccine Adjuvants Market and Drive Its Revenue Growth?

The vaccine adjuvants market covered in this report is segmented –

1) By Product Type: Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, Other Product Types

2) By Route of Application: Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants

3) By Route of Administration: Oral, Intramuscular, Intranasal, Subcutaneous, Intradermal

4) By Disease: Cancer, Infectious Diseases, Other Diseases

Subsegments:

1) By Adjuvant Emulsions: Oil-In-Water Emulsions, Water-In-Oil Emulsions

2) By Pathogen Components: Bacterial Components, Viral Components

3) By Particulate Adjuvants: Liposomes, Nanoparticles, Microparticles

4) By Combination Adjuvants: Mixed Emulsions, Multiple Component Systems

5) By Other Product Types: Synthetic Adjuvants, Natural Adjuvants

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=10121&type=smp

Which Regions Are Emerging as Leaders in the Vaccine Adjuvants Market?

North America was the largest region in the vaccine adjuvants market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global vaccine adjuvants market report during the forecast period. The regions covered in the vaccine adjuvants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Reports Similar to the Gobal Vaccine Adjuvants Maret 2025, By The Business Research Company:

Emulsifiers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/emulsifiers-global-market-report

Chemicals Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/chemicals-global-market-report

Ethylene Global Market Report 2023

https://www.thebusinessresearchcompany.com/report/ethylene-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What key factors are powering the surge in the vaccine adjuvants market right now?

The market size for vaccine adjuvants has seen significant growth in the past few years. The market, which is expected to rise from $1.89 billion in 2024 to $2.03 billion in 2025, boasts a compound annual growth rate (CAGR) of 7.6%. The growth during the historic period is due to several factors including the rise in vaccine development, increasing prevalence of infectious diseases, government support and vaccination campaigns, investments in research and development, as well as the global spread of vaccine distribution.

How fast Is the vaccine adjuvants market expected to grow, and what’s its future value?

In the upcoming years, a significant surge is anticipated in the vaccine adjuvants market, which is projected to reach “$2.89 billion by 2029, reflecting a compound annual growth rate (CAGR) of 9.2%. The expansion projected within this forecast period can be linked to the preparedness for pandemics, enhancing vaccine collections, worldwide vaccination aims, partnerships and joint efforts, as well as an emphasis on therapeutic vaccines. Key trends projected within this period encompass advancements in adjuvant technologies, a focus on amping up immunogenicity, combined adjuvants for improved efficacy, a need for safer and better-tolerated adjuvants, and bespoke vaccines and adjuvants.

Get your vaccine adjuvants market report here!

https://www.thebusinessresearchcompany.com/report/vaccine-adjuvants-global-market-report

What are the leading drivers of growth in the vaccine adjuvants market?

The increasing occurrence of infectious diseases is predicted to fuel the expansion of the vaccine adjuvants market in the future. These infectious diseases are caused by various agents such as viruses, bacteria, fungi, or parasites and are combated using vaccines for illnesses such as hepatitis B (HBV), hepatitis C (HCV), HIV, malaria, syphilis, and brucellosis. For example, the 2022 report by the World Health Organization (WHO) revealed that in 2021, around 10.6 million individuals worldwide contracted tuberculosis, 1.6 million succumbed to the disease, and another 1.5 million people were diagnosed with HIV in the same year, resulting in 650,000 fatalities. Hence, the escalating incidence of such infectious diseases is set to boost the vaccine adjuvants market.

What are the key segments defining the vaccine adjuvants market?

The vaccine adjuvants market covered in this report is segmented –

1) By Product Type: Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, Other Product Types

2) By Route of Application: Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants

3) By Route of Administration: Oral, Intramuscular, Intranasal, Subcutaneous, Intradermal

4) By Disease: Cancer, Infectious Diseases, Other Diseases

Subsegments:

1) By Adjuvant Emulsions: Oil-In-Water Emulsions, Water-In-Oil Emulsions

2) By Pathogen Components: Bacterial Components, Viral Components

3) By Particulate Adjuvants: Liposomes, Nanoparticles, Microparticles

4) By Combination Adjuvants: Mixed Emulsions, Multiple Component Systems

5) By Other Product Types: Synthetic Adjuvants, Natural Adjuvants

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10121&type=smp

Who are the key players steering the development of the vaccine adjuvants market?

Major companies operating in the vaccine adjuvants market include GlaxoSmithKline Plc., Novavax Inc., SPI Pharma Inc., Agenus Inc., CSL Limited, InvivoGen Limited., Brenntag Biosector A/S, Adjuvatis, Merck KGaA, Croda International Plc, Seppic Inc, OZ Biosciences, Avanti Polar Lipids Inc, Astellas Pharma Inc, Virometix AG, MPV Technologies Limited, Adjuvance Technologies Inc., Novartis AG, Vaxine Pty Ltd, SBI Biotech Co. Ltd., Statens Serum Institute, GSK Vaccines, VaxLiant LLC, VaxForm LLC, Serum Institute of India, Dynavax Technologies Corporation, Vaxcyte Inc., VBI Vaccines Inc., Medicago Inc., Aphios Corporation

What emerging trends are influencing the growth of the vaccine adjuvants market?

Emerging trend in the vaccine adjuvants market is notably product innovation. Companies within this market are leveraging innovative solutions to consolidate their positions. For example, Evonik Industries, a chemical manufacturing firm based in Germany, unveiled PhytoSquene, a plant-sourced squalene extracted from amaranth oil in December 2022. This sustainable substitute for traditional shark-sourced squalene is purposed for use in vaccine adjuvants and various other pharmaceutical uses, and it augments vaccine efficiency through immune response intensification. The creation of PhytoSquene exemplifies the mounting emphasis on sustainability within the pharmaceutical industry.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10121

Which regions are most influential in expanding the vaccine adjuvants market?

North America was the largest region in the vaccine adjuvants market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global vaccine adjuvants market report during the forecast period. The regions covered in the vaccine adjuvants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Emulsifiers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/emulsifiers-global-market-report

Chemicals Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/chemicals-global-market-report

Ethylene Global Market Report 2023

https://www.thebusinessresearchcompany.com/report/ethylene-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: